As of March 2021, Takeda Pharmaceutical Co., Ltd. was the leading pharmaceutical company in Japan, managing total assets valued at over 12.9 trillion Japanese yen. Takeda Pharmaceutical is a Tokyo-based company operating worldwide, with a focus on prescription drugs.
Total assets of leading pharmaceutical companies in Japan as of March 2021 (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Statistics on Pharmaceutical industry in Japan
Overview
4
- Premium Statistic Global pharmaceutical market - revenue distribution 2010-2021, by region
- Premium Statistic Number of medical drug manufacturing plants Japan 2021, by production value
- Premium Statistic Total asset of major companies in pharmaceutical industry Japan 2021
- Premium Statistic Volume share of generics in prescription drug market Japan 2005-2021
Production
5
- Premium Statistic Production value of pharmaceutical drugs Japan 2012-2021
- Premium Statistic Share of drug production value Japan 2012-2021, by type
- Premium Statistic Share of drug production value Japan 2021, by category
- Premium Statistic Share of drug production value Japan 2021, by drug form
- Premium Statistic Production value of prescription drugs Japan 2012-2021
International trade
4
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2012-2021
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2012-2021
- Premium Statistic Value of imported pharmaceutical drugs to Japan 2021, by region
- Premium Statistic Value of exported pharmaceutical drugs from Japan 2021, by region
Sales
5
- Premium Statistic Prescription and OTC drug wholesales share in Japan FY 1990-2020
- Premium Statistic Prescription drug market size Japan 2002-2021
- Premium Statistic Share of prescription drug sales Japan FY 2011-2020, by channel
- Premium Statistic Share of prescription drug market Japan 2010-2019 , by category
- Premium Statistic Sales value of leading drugs Japan FY 2021
Expenditure
4
- Premium Statistic R&D spending of pharmaceutical companies in relation to sales Japan FY 2015-2021
- Premium Statistic R&D spending of pharmaceutical companies Japan FY 2015-2021
- Premium Statistic R&D expenditure of leading pharmaceutical manufacturers Japan 2020
- Premium Statistic Ad expenses of the pharmaceuticals industry Japan 2012-2021
Approval and patent
5
- Premium Statistic Number of pharmaceutical products approved by PMDA Japan FY 2020, by type
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2020, by type
- Premium Statistic Number of new drugs approved by PMDA Japan FY 2014-2020
- Premium Statistic Number of patents in the pharmaceutical industry Japan 2021, by type
- Premium Statistic Companies with the highest number of pharmaceutical patent applications Japan 2021
Leading companies
6
- Premium Statistic Major pharmaceutical companies in prescription drug sales Japan 2021, by distributor
- Premium Statistic Net sales of leading generics makers Japan 2020
- Basic Statistic Takeda Pharmaceutical's revenue FY 2012-2021
- Basic Statistic Otsuka Holdings' net sales FY 2012-2021
- Basic Statistic Astellas Pharma's revenue FY 2012-2021
- Basic Statistic Daiichi Sankyo's revenue FY 2012-2021
Coronavirus (COVID-19)
3
Further related statistics
19
- Total assets of the Ipsen group 2014-2019
- Italy: international turnover of leading pharmaceutical companies 2007-2017
- Italy: R&D investments of leading pharmaceutical companies 2007-2017
- Pharmaceutical industry: Italian companies' revenues 2007-2017
- Italy: perception of pharmaceutical companies 2018, by brand
- Research and development expenditure of the Ipsen group 2014-2019
- Fuji Pharma's R&D costs FY 2013-2020
- Astellas Pharma's net profit FY 2012-2021
- Top known pharma companies by Americans 2017
- Pharmaceutical industry: Italian branches worldwide 2016, by area
- Total liabilities of the Ipsen group 2014-2019
- Astellas Pharma's operating profit FY 2012-2021
- Astellas Pharma's R&D expenditure FY 2012-2021
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Top known pharma companies by Americans and gender 2017
- Value of loans to drugs and pharmaceutical industry India 2020, by lender type
- Chugai Pharmaceutical's revenue 2015-2021
- Largest Chinese pharmaceutical companies 2022, by assets
- Personnel costs of the manufacture of pharmaceutical products in Croatia 2010-2019
Further Content: You might find this interesting as well
Statistics
- Total assets of the Ipsen group 2014-2019
- Italy: international turnover of leading pharmaceutical companies 2007-2017
- Italy: R&D investments of leading pharmaceutical companies 2007-2017
- Pharmaceutical industry: Italian companies' revenues 2007-2017
- Italy: perception of pharmaceutical companies 2018, by brand
- Research and development expenditure of the Ipsen group 2014-2019
- Fuji Pharma's R&D costs FY 2013-2020
- Astellas Pharma's net profit FY 2012-2021
- Top known pharma companies by Americans 2017
- Pharmaceutical industry: Italian branches worldwide 2016, by area
- Total liabilities of the Ipsen group 2014-2019
- Astellas Pharma's operating profit FY 2012-2021
- Astellas Pharma's R&D expenditure FY 2012-2021
- Towa Pharmaceutical's employee numbers FY 2012-2017
- Top known pharma companies by Americans and gender 2017
- Value of loans to drugs and pharmaceutical industry India 2020, by lender type
- Chugai Pharmaceutical's revenue 2015-2021
- Largest Chinese pharmaceutical companies 2022, by assets
- Personnel costs of the manufacture of pharmaceutical products in Croatia 2010-2019
Nikkei. (March 8, 2022). Total assets of leading pharmaceutical companies in Japan as of March 2021 (in billion Japanese yen) [Graph]. In Statista. Retrieved February 09, 2023, from https://www.statista.com/statistics/796843/leading-companies-pharmaceutical-drug-sector-by-total-assets-japan/
Nikkei. "Total assets of leading pharmaceutical companies in Japan as of March 2021 (in billion Japanese yen)." Chart. March 8, 2022. Statista. Accessed February 09, 2023. https://www.statista.com/statistics/796843/leading-companies-pharmaceutical-drug-sector-by-total-assets-japan/
Nikkei. (2022). Total assets of leading pharmaceutical companies in Japan as of March 2021 (in billion Japanese yen). Statista. Statista Inc.. Accessed: February 09, 2023. https://www.statista.com/statistics/796843/leading-companies-pharmaceutical-drug-sector-by-total-assets-japan/
Nikkei. "Total Assets of Leading Pharmaceutical Companies in Japan as of March 2021 (in Billion Japanese Yen)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/796843/leading-companies-pharmaceutical-drug-sector-by-total-assets-japan/
Nikkei, Total assets of leading pharmaceutical companies in Japan as of March 2021 (in billion Japanese yen) Statista, https://www.statista.com/statistics/796843/leading-companies-pharmaceutical-drug-sector-by-total-assets-japan/ (last visited February 09, 2023)
Total assets of leading pharmaceutical companies in Japan as of March 2021 (in billion Japanese yen) [Graph], Nikkei, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/796843/leading-companies-pharmaceutical-drug-sector-by-total-assets-japan/